NEW YORK, Oct. 28, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Xiao-I Corporation (NASDAQ: AIXI).Shareholders who purchased shares of AIXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/xiao-i-corporation-loss-submission-form/?id=109405&from=4 CLASS PERIOD: March 9, 2023 ...

LOS ANGELES, Oct. 25, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Xiao-I Corporation ("Xiao-I" or the "Company") (NASDAQ: AIXI). Class Period: March 9, 2023 – July 12, 2024 Lead Plaintiff Deadline: December 16, 2024 If you are a shareholder who suffered a loss, click here to participate. The complaint filed alleges that, throughout the Class Period, Defendants failed to discl ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Xiao-I To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Xiao-I as a result of purchasing (a) Xiao-I American depository shares (ADSs) issued in connection with the Company's initial public offering on or about March 9, 2023 and/or (b) Xiao-I securities between March 9, 2023 and July 12, 2024 and would like to discuss your legal right ...

NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Xiao-I Corporation (NASDAQ: AIXI): (i) American depository shares (“ADSs”) pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering conducted on or about March 9, 2023 (the "IPO" or "Offering"); and/or (ii) securities between March 9, 2023 and July 12, 2024, both dates inclusive (the “Class Period”), of the important December 16 ...

NEWTOWN, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a leading class action law firm, is investigating securities fraud claims on behalf of all investors of Xiao-I Corporation (NASDAQ: AIXI) that purchased or otherwise acquired (a) Xiao-I American depository shares (“ADSs”) pursuant and/or traceable to the Offering Documents issued in connection with the Company’s public offering conducted on or about March 9, 2023; and/or (b) Xiao-I securities between March 9, 2023 and July 12, 2024, inclu ...

Core Viewpoint - Xiao-I Corporation (NASDAQ: AIXI) is facing a class action lawsuit due to allegations of misleading statements and non-compliance with accounting principles, which may have inflated its stock price and misrepresented its financial health [2][4]. Group 1: Allegations and Issues - The class period for the allegations spans from March 9, 2023, to July 12, 2024 [2]. - Allegations include downplaying risks related to non-compliance by Chinese shareholders, which affected the company's ability to utilize offering proceeds [2]. - Xiao-I is accused of failing to comply with Generally Accepted Accounting Principles (GAAP) in its financial statements [2]. - The company allegedly overstated its efforts to address material weaknesses in financial controls [2]. - Significant R&D expenses incurred by Xiao-I to compete in the AI industry were downplayed, impacting business and financial results [2]. - The company is said to have overstated its AI capabilities and resources, leading to potential non-compliance with NASDAQ's Minimum Bid Price Requirement [2]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by December 16, 2024, to potentially become lead plaintiffs [3]. - Registration allows shareholders to receive updates through portfolio monitoring software regarding the case's progress [3]. - Participation in the case incurs no cost or obligation for shareholders [3].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Xiao-I To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Xiao-I as a result of purchasing (a) Xiao-I American depository shares (ADSs) issued in connection with the Company’s initial public offering on or about March 9, 2023 and/or (b) Xiao-I securities between March 9, 2023 and July 12, 2024 and would like to discuss your legal right ...

Core Viewpoint - A class action securities lawsuit has been filed against Xiao-I Corporation, alleging securities fraud that affected investors between March 9, 2023, and July 12, 2024 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that defendants downplayed the risks Xiao-I faced due to non-compliance by certain Chinese shareholders, affecting the company's ability to use offering proceeds for intended business purposes [2]. - It is alleged that Xiao-I failed to comply with Generally Accepted Accounting Principles in its financial statements [2]. - The complaint states that defendants overstated Xiao-I's efforts to address material weaknesses in financial controls [2]. - Significant R&D expenses incurred by Xiao-I to compete in the AI industry were downplayed, impacting the company's business and financial results [2]. - The lawsuit asserts that Xiao-I overstated its AI capabilities, R&D resources, and overall competitiveness in the AI market [2]. - There is a claim that Xiao-I may fail to comply with NASDAQ's Minimum Bid Price Requirement due to these issues [2]. - The offering documents and public statements made during the class period are alleged to be materially false and misleading [2]. Group 2: Next Steps for Investors - Investors who suffered losses in Xiao-I Corporation during the relevant time frame have until December 16, 2024, to request appointment as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. - Participation in the lawsuit does not require serving as a lead plaintiff [3]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a track record of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [3].

Core Viewpoint - A class action lawsuit has been filed against Xiao-I Corporation (NASDAQ: AIXI) for allegedly misleading investors regarding its business prospects and financial disclosures related to its IPO on March 9, 2023 [1]. Group 1: Allegations Against Xiao-I Corporation - The complaint claims that the Offering Documents for the IPO were negligently prepared [1]. - Defendants allegedly downplayed the risks associated with non-compliance by certain Chinese shareholders with Circular 37 Registration, affecting the use of IPO proceeds [1]. - Xiao-I is accused of failing to comply with GAAP in its financial statements [1]. - The company purportedly overstated its efforts to address material weaknesses in financial controls [1]. - Significant R&D expenses incurred by Xiao-I to compete in the AI industry were allegedly downplayed, impacting business and financial results [1]. - The company is accused of overstating its AI capabilities, R&D resources, and overall competitiveness in the AI market [1]. - There is a substantial likelihood that Xiao-I may fail to meet NASDAQ's Minimum Bid Price Requirement due to these issues [1]. Group 2: Class Action Participation - Shareholders may be eligible to participate in the class action against Xiao-I Corporation, with a deadline to apply as lead plaintiff by December 16, 2024 [2]. - A lead plaintiff represents other class members in directing the litigation, but participation is not required for recovery [2]. Group 3: Robbins LLP Overview - Robbins LLP is a recognized leader in shareholder rights litigation, having recovered over $1 billion for shareholders since its inception in 2002 [3].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Xiao-I Corporation's American depository shares (ADSs) related to its initial public offering (IPO) and subsequent securities purchases, alleging misleading statements and non-disclosure of significant risks [1][4]. Group 1: Lawsuit Details - The class action lawsuit pertains to ADSs purchased during the IPO on March 9, 2023, and securities bought between March 9, 2023, and July 12, 2024 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - The lawsuit claims that Xiao-I downplayed risks related to compliance issues with Chinese regulations, specifically Circular 37 Registration, affecting its ability to utilize IPO proceeds [4]. Group 2: Allegations Against Xiao-I - Allegations include failure to comply with U.S. Generally Accepted Accounting Principles (GAAP) in financial statements and overstating efforts to address material weaknesses in financial controls [4]. - The company reportedly incurred significant research and development (R&D) expenses to compete in the AI industry, which were downplayed in public statements [4]. - The lawsuit asserts that these misrepresentations led to a substantial likelihood of failing to meet NASDAQ's listing requirements, including maintaining a minimum closing bid price of $1.00 per share [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and being ranked highly for securities class action settlements [3]. - The firm has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [3].